MD1475G2 - Method of prophylaxis of the puerperal endometritis - Google Patents
Method of prophylaxis of the puerperal endometritisInfo
- Publication number
- MD1475G2 MD1475G2 MD99-0077A MD990077A MD1475G2 MD 1475 G2 MD1475 G2 MD 1475G2 MD 990077 A MD990077 A MD 990077A MD 1475 G2 MD1475 G2 MD 1475G2
- Authority
- MD
- Moldova
- Prior art keywords
- prophylaxis
- puerperal endometritis
- endometritis
- puerperal
- paracervically
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the medicine, in particular to the obstetrics and is used for prophilaxis of puerperal endometritis.The proposed method consists in the administration of a suspension of mononuclear cells culture, obtained from the recipient blood, paracervically in the first 24…48 hours in the puerperium in a single dose of 2 ml.The result of the invention consists in the immunostimulating action and reduction of endogenic intoxication.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD99-0077A MD1475G2 (en) | 1999-02-26 | 1999-02-26 | Method of prophylaxis of the puerperal endometritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD99-0077A MD1475G2 (en) | 1999-02-26 | 1999-02-26 | Method of prophylaxis of the puerperal endometritis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD1475F1 MD1475F1 (en) | 2000-05-31 |
MD1475G2 true MD1475G2 (en) | 2000-12-31 |
Family
ID=19739344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MD99-0077A MD1475G2 (en) | 1999-02-26 | 1999-02-26 | Method of prophylaxis of the puerperal endometritis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD1475G2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1878G2 (en) * | 2001-04-28 | 2002-09-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prophylaxis of the early puerperal endometritis |
MD2396G2 (en) * | 2003-11-13 | 2004-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of the chronic duodenal and recidivating postoperative ulcers |
MD2444G2 (en) * | 2003-09-18 | 2004-12-31 | Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций | Method of prophylaxis of the puersperal endometritis |
-
1999
- 1999-02-26 MD MD99-0077A patent/MD1475G2/en unknown
Non-Patent Citations (2)
Title |
---|
ЗАК, И. Р., СМЕКУНА, Ф. А. Пути снижения материнской летальности при послеродовых инфекционных заболеваниях. Акушерство и гинекология, 1991, № 10, с. 27-30 * |
СМЕКУНА, Ф. А., СУЧИЛЬНИКОВА, И. Н. Иммуномодулятор "Лейкинферон" в профилактике послеродовых инфекционных заболеваний. Тезисы V съезда акушеров-гинекологов и неонатологов Белоруссии. Минск, 1991, с. 203-204 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1878G2 (en) * | 2001-04-28 | 2002-09-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prophylaxis of the early puerperal endometritis |
MD2444G2 (en) * | 2003-09-18 | 2004-12-31 | Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций | Method of prophylaxis of the puersperal endometritis |
MD2396G2 (en) * | 2003-11-13 | 2004-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of the chronic duodenal and recidivating postoperative ulcers |
Also Published As
Publication number | Publication date |
---|---|
MD1475F1 (en) | 2000-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA41995C2 (en) | Sustained release dosage form of azithromycin (variants), method of use, method of manufacture and method for treating infectious diseases in mammals (variants) | |
CA2223433A1 (en) | Ob protein compositions and methods | |
CA2229282A1 (en) | Use of hyaluronic acid as an immunosuppressant | |
IL138424A (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
MXPA03001673A (en) | Lactic acid bacteria capable of reducing an individual s tendency to develop allergic reactions. | |
CA2123049A1 (en) | Pharmaceutical containing the p40 subunit of interleukin 12 | |
HUS1900041I1 (en) | Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation | |
CA2186423A1 (en) | Protein which induces interferon-gamma production by immunocompetent cell | |
HUT38097A (en) | Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances | |
AU1031697A (en) | Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions | |
MD1475G2 (en) | Method of prophylaxis of the puerperal endometritis | |
Cosenza et al. | Cell Interactions in Antibody Formation in Vitro: I. Role of the Third Cell in the in Vitro Response of Spleen Cells to Erythrocyte Antigens | |
Ankel-Fuchs et al. | 7-Mercaptoheptanoylthreonine phosphate functions as component B in ATP-independent methane formation from methyl-CoM with reduced cobalamin as electron donor | |
MD1474F1 (en) | Method of treatment of the puerperal endometritis | |
MD1119G2 (en) | Method for female genitals inflammatory diseases treatment | |
DE69926078D1 (en) | Farnesyl-protein transferase inhibitoren | |
ATE293445T1 (en) | PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO-(5.2.1.0(2.6))-DEC-9-YL-XANTHOGENATE AND THEIR USE AS MEDICINAL PRODUCTS | |
WO2001090316A3 (en) | Human circulating dendritic cell compositions and methods | |
Yoneda et al. | Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation | |
MX9800809A (en) | Process for preparing solid dosage forms of very low-dose drugs. | |
MD1137F1 (en) | Method for treatment of woman sterility | |
UA5743C2 (en) | Preparation of biologically active tissue substances possessing regenerative activity and method for its production | |
MD1135F1 (en) | Paradontium treatment method | |
WO2000022097A3 (en) | Periferal blood mensenchymal precursor cells | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD99 | Pending application |